Cargando…

Causes of Positive Pretransplant Crossmatches in the Absence of Donor-Specific Anti-Human Leukocyte Antigen Antibodies: A Single-Center Experience

Pretransplant crossmatch (XM) testing is widely used for detecting preformed donor-specific antibodies (DSAs) against human leukocyte antigen (HLA). However, in some cases, there is a positive XM result in the absence of HLA-DSAs, the cause of which was rarely identified. We reviewed the causes of s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Hyunhye, Yoo, Jaeeun, Lee, Sang-Yoon, Oh, Eun-Jee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Laboratory Medicine 2021
Materias:	Breif Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884190/ https://www.ncbi.nlm.nih.gov/pubmed/33536364 http://dx.doi.org/10.3343/alm.2021.41.4.429

Ejemplares similares

Laboratory Aspects of Donor Screening for Fecal Microbiota Transplantation at a Korean Fecal Microbiota Bank
por: Seo, Hyun Soo, et al.
Publicado: (2021)

Concordance of Three Automated Procalcitonin Immunoassays at Medical Decision Points
por: Cho, Hae Weon, et al.
Publicado: (2021)

Phospholipase C Beta 2 Protein Overexpression Is a Favorable Prognostic Indicator in Newly Diagnosed Normal Karyotype Acute Myeloid Leukemia
por: Park, Mi Suk, et al.
Publicado: (2021)

Revision hip arthroplasty in sickle cell disease
por: Kalacý, Aydýner, et al.
Publicado: (2007)

Cloning and further sequence analysis of the spike gene of attenuated porcine epidemic diarrhea virus DR13
por: Park, Seong-Jun, et al.
Publicado: (2006)

Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia
por: Eapen, Mary, et al.
Publicado: (2020)

A Stabilizing Agent, PCA/DTPA, Improves Plasma Storage Life for the Chromsystems Vitamin C Assay up to Six Months
por: Collie, Jake TB, et al.
Publicado: (2021)

Clinical Relevance of Pretransplant HLA Class II Donor-specific Antibodies in Renal Transplantation Patients with Negative T-cell Cytotoxicity Crossmatches
por: Song, Eun Young, et al.
Publicado: (2012)

Correlation of Pretransplant Donor-specific Antibody Assay Using Luminex Crossmatch with Graft Outcome in Renal Transplant Patients
por: Vimal, M., et al.
Publicado: (2017)

Comparison of Physical Crossmatch and Virtual Crossmatch to Identify Preexisting Donor-Specific Human Leukocyte Antigen (HLA) Antibodies and Outcome Following Kidney Transplantation
por: Peng, Bo, et al.
Publicado: (2019)

Human leukocyte antigen typing and crossmatch: A comprehensive review
por: Althaf, Mohammed Mahdi, et al.
Publicado: (2017)

Combining Sensitive Crossmatch Assays With Donor/Recipient Human Leukocyte Antigen Eplet Matching Predicts Living-Donor Kidney Transplant Outcome
por: Meneghini, Maria, et al.
Publicado: (2018)

Nonspecific positivity on the Luminex crossmatch assay for anti-human leukocyte antigen antibodies due to antibodies directed against the antibody coated beads
por: Chacko, M. P., et al.
Publicado: (2016)

New Insights Into SARS-CoV-2-specific Antibody Levels in Kidney Transplantation Recipients After Three Vaccination Doses
por: Kang, Hyunhye, et al.
Publicado: (2024)

Approach to the Pretransplant Evaluation of the Living Kidney Donor
por: Sachdeva, Mala, et al.
Publicado: (2011)

Impact of low‐level pretransplant donor‐specific antibodies on outcomes after kidney transplantation
por: Parajuli, Sandesh, et al.
Publicado: (2021)

BSHI/BTS guidance on crossmatching before deceased donor kidney transplantation
por: Peacock, S., et al.
Publicado: (2021)

Development of Proliferating Cell Nuclear Antigen Autoantibodies With the Manifestation of Graft Versus Host Disease After Peripheral Blood Stem Cell Transplantation
por: Kang, Hyunhye, et al.
Publicado: (2023)

Impact of Low-level Donor-specific Antibody Determined With a Positive Luminex and Negative Flow Cytometric Crossmatch on Kidney Transplantation Outcomes
por: Nam, Minjeong, et al.
Publicado: (2023)

Clinical significance of the presence of anti-human leukocyte antigen-donor specific antibody in kidney transplant recipients with allograft dysfunction
por: Chung, Byung Ha, et al.
Publicado: (2018)

C1Q Assay Results in Complement-Dependent Cytotoxicity Crossmatch Negative Renal Transplant Candidates with Donor-Specific Antibodies: High Specificity but Low Sensitivity When Predicting Flow Crossmatch
por: Arreola-Guerra, José M., et al.
Publicado: (2016)

ELISA-Based Crossmatching Allowing the Detection of Emerging Donor-Specific Anti-HLA Antibodies through the Use of Stored Donors' Cell Lysates
por: Schlaf, G., et al.
Publicado: (2015)

Accuracy of point‐of‐care crossmatching methods and crossmatch incompatibility in critically ill dogs
por: Marshall, Hayden, et al.
Publicado: (2020)

Living donor liver transplantation using sensitized lymphocytotoxic crossmatch positive graft
por: Aoki, Taku, et al.
Publicado: (2012)

Combined Analysis of HLA Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of De Novo Donor Specific Antibody Development in Kidney Transplant Recipients
por: Lee, Hyeyoung, et al.
Publicado: (2022)

Implication of a positive virtual crossmatch with negative flow crossmatch: A mind-boggler
por: Chowdhry, Mohit, et al.
Publicado: (2020)

Pretransplant Infusion of Donor B Cells Enhances Donor-Specific Skin Allograft Survival
por: Gao, Julia, et al.
Publicado: (2013)

Pretransplant Donor-Specific Anti-HLA Antibodies and the Risk for Rejection-Related Graft Failure of Kidney Allografts
por: Betjes, Michiel G. H., et al.
Publicado: (2020)

False Positive B-Cells Crossmatch after Prior Rituximab Exposure of the Kidney Donor
por: Desoutter, Judith, et al.
Publicado: (2016)

The effect of a positive T-lymphocytotoxic crossmatch on clinical outcomes in adult-to-adult living donor liver transplantation
por: Kim, Young-Kyu, et al.
Publicado: (2013)

Immediate transfusion without crossmatching
por: Moriwaki, Y, et al.
Publicado: (2008)

B-cell Complement Dependent Cytotoxic Crossmatch Positivity is an Independent Risk Factor for Long-term Renal Allograft Survival
por: Hwang, Hyeon Seok, et al.
Publicado: (2011)

The CDC crossmatch in the era of flow cytometric cross-match and single antigen beads
por: Mahowald, Grace Kao
Publicado: (2021)

Potential serological challenges caused by anti-IH antibody in the crossmatch laboratory
por: Raturi, Manish, et al.
Publicado: (2021)

Antibody Therapeutics as Interfering Agents in Flow Cytometry Crossmatch for Organ Transplantation
por: Kueht, Michael L., et al.
Publicado: (2023)

Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant Recipients
por: Morrison, Alexander H., et al.
Publicado: (2019)

Interlaboratory Comparison of the Results of Lifecodes LSA Class I and Class II Single Antigen Kits for Human Leukocyte Antigen Antibody Detection
por: Oh, Eun-Jee, et al.
Publicado: (2015)

Impact of pretransplant antibodies on outcomes after heart transplantation
por: Nunoda, Shinichi
Publicado: (2019)

Absence of association between pretransplant serum soluble programmed death protein-1 level and prognosis following living donor liver transplantation in patients with hepatocellular carcinoma
por: Na, Byeong-Gon, et al.
Publicado: (2021)

Meneghini M, Melilli E, Martorell J, et al. Combining sensitive crossmatch assays with donor/recipient human leukocyte antigen eplet matching predicts living-donor kidney transplant outcome. Kidney Int Rep. 2018;3:926–938
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vopc7fdoop2njav3pg6p35gq6q